Today, on
Resolution on adoption of accounts and allocation of the company's result
The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet. The annual general meeting also resolved in accordance with the proposal from the Board to allocate the company's result, meaning that no dividends are paid and that unappropriated earnings are carried forward to a new account.
Discharge from liability for the members of the Board and the CEO
The annual general meeting resolved to discharge the Board members and the CEO from liability for the financial year 2023.
Election and remuneration of the Board and auditors
The annual general meeting resolved in accordance with the proposal from the Nomination Committee to re-elect Cecilia Jinert Johansson,
Furthermore, the annual general meeting resolved in accordance with the proposal from the Nomination Committee that remuneration to the Board shall be paid with
Finally, the annual general meeting resolved in accordance with the proposal from the Nomination Committee to re-elect
Instruction for the Nomination Committee
The annual general meeting resolved in accordance with the proposal from the Nomination Committee that a Nomination Committee shall be appointed before coming election and remuneration. The Nomination Committee shall consist of three members representing the three largest shareholders as of the last calendar day in
Resolution on approval of remuneration report
The annual general meeting resolved to approve the Board's remuneration report for the financial year 2023.
Resolution on guidelines for remuneration to senior executives
The annual general meeting resolved in accordance with the proposal from the Board to adopt new guidelines for remuneration to the company's senior executives.
Resolution on authorization regarding issues
The annual general meeting resolved in accordance with the proposal from the Board to authorize the Board, at one or several occasions, during the time up until the next annual general meeting, with or without deviation from the shareholders' preferential rights, to resolve to issue new shares, convertibles and/or warrants. Issues may be made with or without provisions regarding payment in kind or through set-off or other provisions. The total number of shares that may be issued pursuant to the authorization (alternatively be issued through conversion of warrants and/or exercise of convertibles) shall not exceed 20,228,950 shares, which corresponds to an aggregate dilution of approximately 20 per cent calculated on the number of outstanding shares in the company. The purpose of the authorization, and the reason for any eventual deviation from the shareholders' preferential rights, is to give the Board flexibility in its work to ensure that the company can appropriately be provided with capital for the financing of the business and to enable continued expansion both organically and through acquisitions, or to be able to expand the ownership with one or more owners of strategic importance. To the extent an issue is made with deviation from the shareholders' preferential rights, the issue should be made on market terms (subject to customary new issue discount, as applicable).
Resolution on a directed issue of warrants, series 2024/2027
The annual general meeting resolved in accordance with the proposal from the Board on a directed issue of a maximum of 1,700,000 warrants entitling to subscription of new shares in the company.
The right to subscribe for the warrants shall, with deviation from the shareholders' preferential rights, vest in the CEO, management and other employees of the company or the
Each warrant shall entitle the holder to, during the period from and including
The reason for deviating from the shareholders' preferential rights is a desire to introduce a warrant program intended for allotment to key employees in the company, whereby they can be offered the opportunity to take part in a value increase of the company's share. This is expected to strengthen the interest in the company's development - as well as the company's share price development - and to stimulate continued company loyalty in the coming years.
Lomma on
For more information, please contact:
Ronnie Törnqvist, CEO, +46-706 25 41 85, ronnie.tornqvist@nexamchemical.com
This information was submitted for publication, through the agency of the contact person set out above, at 16.45 CEST on
About
https://news.cision.com/nexam-chemical/r/bulletin-from-the-annual-general-meeting-in-nexam-chemical-holding-ab--publ--on-may-14-2024,c3979738
https://mb.cision.com/Main/6364/3979738/2796703.pdf
(c) 2024 Cision. All rights reserved., source